A Pulsed Field Ablation-Based Endocardial Strategy for Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy | JACC: Clinical Electrophysiology

A Pulsed Field Ablation-Based Endocardial Strategy for Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy | JACC: Clinical Electrophysiology

From JACC Specialty Journals by American College of Cardiology

April 23, 2026 · 4 min

About this episode

Dr. Francis Marchlinski discusses a novel pulsed field ablation strategy for treating ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy.

In this podcast, Francis Marchlinski, MD, Deputy Editor of JACC: Clinical Electrophysiology, discusses a novel pulsed field ablation–based endocardial strategy for ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy. The paper presents an early consecutive experience demonstrating the feasibility, acute effectiveness, and safety of PFA for VT without the need for epicardial access. Dr. Marchlinski highlights the clinical implications of this approach and how tissue-selective, nonthermal energy may expand treatment options for this challenging patient population.

People in this episode

Guest: Francis Marchlinski, MD

Topics covered

  • pulsed field ablation
  • ventricular tachycardia
  • arrhythmogenic right ventricular cardiomyopathy
  • clinical implications
  • treatment options

Keywords

  • pulsed field ablation
  • ventricular tachycardia
  • arrhythmogenic right ventricular cardiomyopathy
  • clinical implications
  • treatment options
  • nonthermal energy
  • safety
  • effectiveness

Mentioned in this episode

Organizations: JACC: Clinical Electrophysiology, American College of Cardiology

Books & works: pulsed field ablation, ventricular tachycardia, arrhythmogenic right ventricular cardiomyopathy

More episodes of JACC Specialty Journals

Explore listener stats, chart rankings, contacts and more on the JACC Specialty Journals podcast page.